Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The biological lipid bilayers and surface interfaces in the ear canal primarily consist of the stratum corneum of the external auditory canal and the overlying cerumen layer [1]. This interface serves as a critical protective barrier, preventing water penetration and maintaining an acidic environment (pH 5.0–5.7) to inhibit pathogen growth [2]. It also facilitates the self-cleaning mechanism of the ear through epithelial migration, which moves debris and cerumen toward the canal opening [1]. Cerumen itself is a complex mixture of saturated and unsaturated long-chain fatty acids, alcohols, squalene, and cholesterol, providing both lubrication and antimicrobial properties [3]. In clinical pharmacology, these interfaces are not traditional molecular targets like receptors or enzymes; rather, they act as the primary pharmacokinetic barrier for topical otic medications [4]. Drugs such as cerumenolytics interact with these lipid interfaces by inducing chemical disintegration or softening of the wax, while acidifying agents modify the surface pH to treat infections like otitis externa [5]. Disruption of this lipid-rich interface, often through excessive cleaning or water exposure, can lead to inflammatory conditions and increased susceptibility to bacterial or fungal infections [2]. Understanding the integrity of these bilayers is essential for the effective delivery of topical antibiotics and steroids to the underlying tissues [4]. Sources: [1] StatPearls, Anatomy, Head and Neck, Ear External Auditory Canal (2023). [2] PubMed, The role of cerumen in the health of the external auditory canal, Journal of Laryngology & Otology (2011). [3] PubMed, Composition of cerumen, American Journal of Otology (1990). [4] Journal of Pharmaceutical Sciences, Topical drug delivery to the ear: Physicochemical considerations (2014). [5] Mayo Clinic, Earwax blockage: Diagnosis and treatment (2023).
Physical dissolution of lipids, alteration of surface tension, acidification of the interface to inhibit microbial growth, or acting as a solvent for cerumen disintegration.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biological lipid bilayers and surface interfaces of the external auditory canal.